重建算法与扫描仪特性表征对[123I]FP-CIT SPECT正常数据库诊断能力的影响
本研究评估不同断层重建方式及系统特性表征对[123I]FP-CIT SPECT正常数据库诊断性能的影响,纳入两个中心77例有3年临床随访的[123I]FP-CIT SPECT检查,以随访临床诊断为标准,比较三种重建方式与两种定量方法。结果显示BRASS定量时各重建与校准策略间诊断性能无显著差异,而Southampton定量法的敏感性受重建与校准策略影响显著。
要点
- BRASS定量时,各重建方式与系统校准策略间诊断性能无显著差异,ROC曲线下面积为0.866至0.924。
- Southampton法定量时,敏感性在ACSC校准(90.7%)与IRNC校准(76.7%)、FBP校准(67.4%)间存在显著差异。
- Southampton法使用ACSC重建时,校准后敏感性(90.7%)显著优于未校准(65.1%)。
核心结论
- 使用BRASS定量时,正常[123I]FP-CIT SPECT数据库评估临床扫描正常与否的能力在所有重建、系统特性表征和定量策略间相当。
- 使用Southampton定量方法时,诊断性能对所用的重建和校准策略敏感。
研究设计与样本
- 研究纳入两个中心的77例[123I]FP-CIT SPECT检查,均有3年临床随访,以随访临床诊断为标准真值。
- 患者与正常数据分别采用带衰减、散射和隔片穿透校正的迭代重建(ACSC)、不带校正的迭代重建(IRNC)及滤波反投影(FBP)进行重建。
- 定量分析采用小体积感兴趣区(BRASS)和大体积感兴趣区(Southampton)两种方法,分别在有和无系统特性表征条件下评估诊断性能,采用ROC分析(年龄无关数据)及年龄匹配正常值的敏感性/特异性分析。
主要发现
- 年龄无关的扫描正常性定量评估在各重建、系统特性表征和定量方法间无显著差异,ROC曲线下面积为0.866至0.924。
- BRASS定量时,所有重建与校准策略间敏感性(67.4%至83.7%)和特异性(79.4%至91.2%)均无显著差异。
- Southampton法定量时,校准条件下敏感性在ACSC重建(90.7%)与IRNC重建(76.7%)、FBP重建(67.4%)间存在显著差异。
- Southampton法使用ACSC重建时,校准后敏感性(90.7%)显著优于未校准(65.1%)。
- Southampton法定量时,特异性在各重建与校准选择间保持不变,为82.4%至88.2%。
关键数值与推荐
- 采用BRASS定量时,敏感性范围为67.4%至83.7%,特异性范围为79.4%至91.2%,各重建与校准策略间无显著差异。
- 采用Southampton法定量且校准条件下,ACSC重建敏感性为90.7%,IRNC重建为76.7%,FBP重建为67.4%,ACSC与IRNC、FBP间差异显著。
- 采用Southampton法ACSC重建时,校准后敏感性为90.7%,未校准为65.1%,校准后显著更优。
- 采用Southampton法定量时,特异性在各重建与校准选择间为82.4%至88.2%,保持不变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of a normal database for [123I]FP-CIT SPECT imaging has been found to be helpful for cases which are difficult to interpret by visual assessment alone, and to improve reproducibility in scan interpretation. The aim of this study was to assess whether the use of different tomographic reconstructions affects the performance of a normal [123I]FP-CIT SPECT database and also whether systems benefit from a system characterisation before a database is used. Seventy-seven [123I]FP-CIT SPECT studies from two sites and with 3-year clinical follow-up were assessed quantitatively for scan normality using the ENC-DAT normal database obtained in well-documented healthy subjects. Patient and normal data were reconstructed with iterative reconstruction with correction for attenuation, scatter and septal penetration (ACSC), the same reconstruction without corrections (IRNC), and filtered back-projection (FBP) with data quantified using small volume-of-interest (VOI) (BRASS) and large VOI (Southampton) analysis methods. Test performance was assessed with and without system characterisation, using receiver operating characteristics (ROC) analysis for age-independent data and using sensitivity/specificity analysis with age-matched normal values. The clinical diagnosis at follow-up was used as the standard of truth. RESULTS: There were no significant differences in the age-independent quantitative assessment of scan normality across reconstructions, system characterisation and quantitative methods (ROC AUC 0.866-0.924). With BRASS quantification, there were no significant differences between the values of sensitivity (67.4-83.7%) or specificity (79.4-91.2%) across all reconstruction and calibration strategies. However, the Southampton method showed significant differences in sensitivity between ACSC (90.7%) vs IRNC (76.7%) and FBP (67.4%) reconstructions with calibration. Sensitivity using ACSC reconstruction with this method was also significantly better with calibration than without calibration (65.1%). Specificity using the Southampton method was unchanged across reconstruction and calibration choices (82.4-88.2%). CONCLUSIONS: The ability of a normal [123I]FP-CIT SPECT database to assess clinical scan normality is equivalent across all reconstruction, system characterisation, and quantification strategies using BRASS quantification. However, when using the Southampton quantification method, performance is sensitive to the reconstruction and calibration strategy used.
引用
- Dickson JC, Tossici-Bolt L, Sera T, et al. The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging. EJNMMI Res. 2017. PMID: 28120177. doi:10.1186/s13550-016-0253-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。